Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

References

• SingelKLSegalBHNeutrophils in the tumor microenvironment: trying to heal the wound that cannot healImmunol Rev2016273132934327558344
   PubMed Web of Science ®Google Scholar
• MosesKBrandauSHuman neutrophils: Their role in cancer and relation to myeloid-derived suppressor cellsSemin Immunol201628218719627067179
   PubMed Web of Science ®Google Scholar
• PinkertonJWKimRYRobertsonAABInflammasomes in the lungMol Immunol201786445528129896
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• KimEYKimNKimYSPrognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALIPLoS One20161110e016405627706243
   PubMed Web of Science ®Google Scholar
• VanoYAOudardSByMAOptimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patientsPLoS One2018134e019504229624591
   PubMed Web of Science ®Google Scholar
• PengBWangYHLiuYMMaLXPrognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysisInt J Clin Exp Med2015833098310626064198
   PubMed Web of Science ®Google Scholar
• SacdalanDBLuceroJASacdalanDLPrognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysisOnco Targets Ther20181195596529503570
   PubMed Web of Science ®Google Scholar
• KiriuTYamamotoMNaganoTThe time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancerPLoS One2018132e019301829447258
   PubMed Web of Science ®Google Scholar
• WangXTengFKongLYuJPretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancerOnco Targets Ther201695761577027703374
   PubMed Web of Science ®Google Scholar
• DengMMaXLiangXZhuCWangMAre pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?Oncotarget2017823372003720728380461
   PubMedGoogle Scholar
• FukuiTOkumaYNakaharaYActivity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational StudyClin Lung Cancer Epub201855
   Web of Science ®Google Scholar
• BowenRCLittleNABHarmerJRNeutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysisOncotarget2017819321713218928418870
   PubMedGoogle Scholar
• ZhangHZhangLZhuKPrognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort StudyPLoS One2015105e012649625950176
   PubMed Web of Science ®Google Scholar
• YangHBXingMMaLNFengLXYuZPrognostic significance of neutrophil-lymphocyte ratio/platelet-lymphocyte ratio in lung cancers: a meta-analysisOncotarget2016747767697677827732958
   PubMed Web of Science ®Google Scholar
• CannonNAMeyerJIyengarPNeutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancerJ Thorac Oncol201510228028525299234
   PubMed Web of Science ®Google Scholar
• AkamineTTakadaKToyokawaGAssociation of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markersSurg Oncol2018271889429549910
   PubMed Web of Science ®Google Scholar
• ZerASungMRWaliaPCorrelation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung CancerClin Lung Cancer2018195426434.e129803574
   PubMed Web of Science ®Google Scholar
• ZelenMKeynote address on biostatistics and data retrievalCancer Chemother Rep 31973423142
   PubMedGoogle Scholar
• KäsmannLBolmLSchildSEJanssenSRadesDNeutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung CancerLung2017195221722428154994
   PubMed Web of Science ®Google Scholar
• GiraldoNABechtEVanoYSautès-FridmanCFridmanWHThe immune response in cancer: from immunology to pathology to immunotherapyVirchows Arch2015467212713526077464
   PubMed Web of Science ®Google Scholar
• ShrotriyaSWalshDBennani-BaitiNThomasSLortonCC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewPLoS One20151012e014308026717416
   PubMed Web of Science ®Google Scholar
• LeuzziGGaleoneCGisabellaMBaseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysisTumori2016102544144927292573
   PubMed Web of Science ®Google Scholar
• DolanRDMcSorleySTHorganPGLairdBMcMillanDCThe role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysisCrit Rev Oncol Hematol201711613414628693795
   PubMed Web of Science ®Google Scholar
• FangYXuCWuPPrognostic role of C-reactive protein in patients with nasopharyngeal carcinomaMedicine (Baltimore)20179645e846329137033
   PubMed Web of Science ®Google Scholar
• GroseDMorrisonDSDevereuxGScottish Lung Cancer ForumThe impact of comorbidity upon determinants of outcome in patients with lung cancerLung Cancer201587218619225498829
   PubMed Web of Science ®Google Scholar
• ZhouYChengSFathyAHQianHZhaoYPrognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studiesOnco Targets Ther2018111899190829670365
   PubMed Web of Science ®Google Scholar
• CatacchioIScattoneASilvestrisNMangiaAImmune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune MarkersTransl Oncol201811382583529729581
   PubMed Web of Science ®Google Scholar
• ThamTBardashYHermanSWCostantinoPDNeutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysisHead Neck Epub2018514
   Web of Science ®Google Scholar
• WangYPengCChengZThe prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysisInt J Surg201855738029787804
   PubMed Web of Science ®Google Scholar
• ZhanHMaJYJianQCPrognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysisClin Chim Acta201848413614029856976
   PubMed Web of Science ®Google Scholar
• YuYQianLCuiJValue of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patientsMol Clin Oncol20177349850628811903
   PubMedGoogle Scholar
• KangMHGoSISongHNThe prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancerBr J Cancer2014111345246024921916
   PubMed Web of Science ®Google Scholar
• LiuDHuangYLiLSongJZhangLLiWHigh neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancerBMC Cancer201717188229268698
   PubMedGoogle Scholar
• SuzukiRLinSHWeiXPrognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancerRadiother Oncol2018126349950529398150
   PubMed Web of Science ®Google Scholar
• WenQMengXXiePWangSSunXYuJEvaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapyOncotarget2017846814058141829113400
   PubMedGoogle Scholar
• AntoniaSJLópez-MartinJABendellJNivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (Check-Mate 032): a multicentre, open-label, phase 1/2 trialLancet Oncol201617788389527269741
   PubMed Web of Science ®Google Scholar
• No authors listedAbstracts DEGRO 2018Strahlenther Onkol2018194Suppl 11222
   Google Scholar